Page last updated: 2024-10-31

mitoxantrone and Polycystic Kidney Diseases

mitoxantrone has been researched along with Polycystic Kidney Diseases in 1 studies

Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.

Polycystic Kidney Diseases: Hereditary diseases that are characterized by the progressive expansion of a large number of tightly packed CYSTS within the KIDNEYS. They include diseases with autosomal dominant and autosomal recessive inheritance.

Research Excerpts

ExcerptRelevanceReference
"We report the second case of acute promyelocytic leukemia (APL), which developed post-transplant and immunosuppressive treatment, in a 50-year-old male who had undergone a renal transplant."1.31Acute promyelocytic leukemia with additional chromosome abnormalities in a renal transplant case. ( Cuneo, A; Liso, V; Mestice, A; Pannunzio, A; Rocchi, M; Specchia, G; Storlazzi, CT; Surace, C, 2001)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Specchia, G1
Storlazzi, CT1
Cuneo, A1
Surace, C1
Mestice, A1
Pannunzio, A1
Rocchi, M1
Liso, V1

Other Studies

1 other study available for mitoxantrone and Polycystic Kidney Diseases

ArticleYear
Acute promyelocytic leukemia with additional chromosome abnormalities in a renal transplant case.
    Annals of hematology, 2001, Volume: 80, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Chromosomes, Human, Pair 1;

2001